|
Oct 16
|
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
|
|
Sep 27
|
High Growth Tech Stocks in the United States to Watch
|
|
Sep 25
|
Rigel (RIGL) Surges 19.7%: Is This an Indication of Further Gains?
|
|
Sep 6
|
Rigel enrols first participant in Phase Ib/II AML treatment regimen trial
|
|
Sep 5
|
Rigel Announces First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA® (olutasidenib) in mIDH1 AML
|
|
Sep 3
|
Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan
|
|
Aug 29
|
With 45% stake, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) seems to have captured institutional investors' interest
|
|
Jul 30
|
Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jul 30
|
Rigel Announces Conference Call and Webcast to Report Second Quarter 2024 Financial Results and Business Update
|
|
Jun 25
|
Rigel Announces Reverse Stock Split
|
|
Jun 24
|
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
|
|
Jun 14
|
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
|
|
Jun 6
|
Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders have endured a 76% loss from investing in the stock three years ago
|
|
May 10
|
Rigel (RIGL) Upgraded to Buy: Here's What You Should Know
|
|
May 10
|
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Analysts Are Pretty Bullish On The Stock After Recent Results
|
|
May 8
|
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
|
|
May 8
|
Rigel Pharmaceuticals Inc (RIGL) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves ...
|
|
May 7
|
Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags Revenue Estimates
|
|
May 7
|
Rigel Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 2
|
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|